U.S. Softgel Capsules Market Size & Outlook, 2022-2030
U.S. softgel capsules market, 2018-2030 (US$M)
Related Markets
U.S. softgel capsules market highlights
- The U.S. softgel capsules market generated a revenue of USD 2,044.8 million in 2022 and is expected to reach USD 3,662.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
- In terms of segment, gelatin-based/animal-based was the largest revenue generating type in 2022.
- Non-Animal-Based is the most lucrative type segment registering the fastest growth during the forecast period.
Softgel capsules market data book summary
| Market revenue in 2022 | USD 2,044.8 million |
| Market revenue in 2030 | USD 3,662.0 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Gelatin-based/animal-based |
| Fastest growing segment | Non-Animal-Based |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gelatin-Based/Animal-Based, Non-Animal-Based |
| Key market players worldwide | Thermo Fisher Scientific Inc, EyePoint Pharmaceuticals Inc, Catalent Inc, Kuehne + Nagel International AG, Lonza Group Ltd, Procaps Group SA, Soft Gel Technologies, EuroCaps, Captek Softgel International, Sirio Pharma, Fuji Capsule |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.7% of the global softgel capsules market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. softgel capsules market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,662.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Softgel Capsules Market Scope
Softgel Capsules Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. softgel capsules market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to softgel capsules market will help companies and investors design strategic landscapes.
Gelatin-based/animal-based was the largest segment with a revenue share of 68.56% in 2022. Horizon Databook has segmented the U.S. softgel capsules market based on gelatin-based/animal-based, non-animal-based covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. dominated the overall global softgel market in terms of revenue in 2021, with a market share of 38.72%. According to the 2020 Centers for Medicare and Medicaid Services data, the U.S. spends nearly 19.7% of its GDP on healthcare.
The increasing prevalence of several diseases in the country such as diabetes, cardiovascular diseases, and obesity are some of the key factors expected to boost market growth during the forecast period.
According to the American Heart Association, the data derived from the Nation Health and Nutrition Examination survey suggested that there were an estimated 28.2 Million adults diagnosed with diabetes, 113.6 Million adults had prediabetes, and about 9.8 Million people had undiagnosed diabetes.
Reasons to subscribe to U.S. softgel capsules market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. softgel capsules market databook
-
Our clientele includes a mix of softgel capsules market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. softgel capsules market , including forecasts for subscribers. This country databook contains high-level insights into U.S. softgel capsules market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. softgel capsules market size, by type, 2018-2030 (US$M)
U.S. Softgel Capsules Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
